| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
cyclin dependent kinase inhibitor 2D | 0.547 | 0.769 | 0.49 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 1996 | 1996 | ||||||||
|
Ras association domain family member 1 | 0.420 | 0.808 | 4.9E-06 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2004 | 2004 | ||||||||
|
H3 histone pseudogene 13 | 0.584 | 0.769 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 1996 | 1996 | |||||||||
|
T cell leukemia homeobox 3 | 0.674 | 0.462 | 0.26 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2019 | 2019 | ||||||||
|
hematopoietic cell-specific Lyn substrate 1 | 0.539 | 0.846 | 1.3E-06 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2018 | 2018 | ||||||||
|
neural cell adhesion molecule 1 | 0.415 | 0.885 | 1.00 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 2014 | 2014 | ||||||||
|
interleukin 23 subunit alpha | 0.415 | 0.846 | 0.36 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 1996 | 1996 | ||||||||
|
FES proto-oncogene, tyrosine kinase | 0.593 | 0.769 | 3.8E-15 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 1984 | 1984 | ||||||||
|
regenerating family member 1 alpha | 0.467 | 0.846 | 1.3E-05 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 1996 | 1996 | ||||||||
|
coagulation factor IX | 0.465 | 0.885 | 1.00 |
|
group | 0.010 | None | < 0.001 | 1 | 0 | 1996 | 1996 | ||||||||
|
Rho GTPase activating protein 24 | 0.456 | 0.808 | 3.9E-10 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 1999 | 1999 | ||||||||
|
tumor protein p73 | 0.449 | 0.808 | 1.00 |
|
group | 0.020 | None | 0.500 | 2 | 0 | 1999 | 1999 | ||||||||
|
signal transducer and activator of transcription 5A | 0.445 | 0.808 | 1.00 |
|
group | 0.050 | None | 0.800 | 5 | 0 | 2002 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 2A | 0.300 | 0.885 | 0.39 |
|
group | 0.080 | None | 0.875 | 8 | 0 | 1995 | 2013 | ||||||||
|
signal transducer and activator of transcription 5B | 0.442 | 0.808 | 1.00 |
|
group | 0.090 | None | 0.889 | 9 | 0 | 2002 | 2019 | ||||||||
|
ABL proto-oncogene 1, non-receptor tyrosine kinase | 0.432 | 0.923 | 1.00 |
|
group | 0.100 | None | 1.000 | 10 | 0 | 2003 | 2018 | ||||||||
|
RUNX family transcription factor 1 | 0.425 | 0.808 | 0.65 |
|
group | 0.090 | None | 1.000 | 9 | 0 | 1999 | 2017 | ||||||||
|
BCR activator of RhoGEF and GTPase | 0.431 | 0.885 | 0.99 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 1998 | 2019 | ||||||||
|
Janus kinase 2 | 0.385 | 0.885 | 0.65 |
|
group | 0.080 | None | 1.000 | 8 | 0 | 2006 | 2019 | ||||||||
|
tet methylcytosine dioxygenase 2 | 0.458 | 0.808 | 4.3E-54 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 2013 | 2019 | ||||||||
|
MYC proto-oncogene, bHLH transcription factor | 0.344 | 0.923 | 1.00 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 1983 | 2017 | ||||||||
|
ETS variant transcription factor 6 | 0.477 | 0.731 | 0.97 |
|
group | 0.360 | None | 1.000 | 7 | 0 | 1995 | 2015 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
group | 0.070 | None | 1.000 | 7 | 0 | 1989 | 2019 | ||||||||
|
H3 histone pseudogene 10 | 0.350 | 0.846 |
|
group | 0.060 | None | 1.000 | 6 | 0 | 1995 | 2004 | |||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
group | 0.060 | None | 1.000 | 6 | 1 | 1991 | 2011 |